Literature DB >> 26615424

MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.

Wei Ding1, Hongbo Tan2, Chen Zhao3, Xuemei Li4, Zhiqiang Li5, Changli Jiang4, Yue Zhang4, Lan Wang4.   

Abstract

MicroRNAs (miRNAs) play key roles in cancer development and progression. In the present study, we investigated the role of miR-145 in the progression of hepatocellular carcinoma (HCC). Ten HCC cell lines and samples from 96 patients with HCC were analyzed for the expression of miR-145 by quantitative real-time polymerase chain reaction (qRT-PCR). Overexpression of miR-145 was established by transfecting mimics into HepG2 and QGY-7703 cells. Cell proliferation and cell migration were assessed by cell viability assay and transwell assay. Western blot was to verify ROCK1 as a novel target gene of miR-145. Our results showed that miR-145 was frequently downregulated in HCC tumors and cell lines. Overexpression of miR-145 in HCC cell lines significantly inhibited cell proliferation, migration, and invasion in vitro. ROCK1 was identified as a target of miR-145, and ectopic expression of miR-145 downregulated ROCK1. Together, these findings indicate that miR-145 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression and metastasis of HCC through a mechanism involving ROCK1, suggesting miR-145 as a potential new diagnostic and therapeutic target for the treatment of HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; MiR-145; Migration; Proliferation; ROCK1

Mesh:

Substances:

Year:  2015        PMID: 26615424     DOI: 10.1007/s13277-015-4462-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

Review 1.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

2.  Micro RNA profiling: an easy and rapid method to screen and characterize stem cell populations.

Authors:  Uma Lakshmipathy; Brad Love; Christopher Adams; Bhaskar Thyagarajan; Jonathan D Chesnut
Journal:  Methods Mol Biol       Date:  2007

3.  RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.

Authors:  Wei Ma; Carmen Chak-Lui Wong; Edmund Kwok-Kwan Tung; Chun Ming Wong; Irene Oi-Lin Ng
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

4.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

5.  miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.

Authors:  T Chiyomaru; H Enokida; S Tatarano; K Kawahara; Y Uchida; K Nishiyama; L Fujimura; N Kikkawa; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

6.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.

Authors:  Xi Chen; Yi Ba; Lijia Ma; Xing Cai; Yuan Yin; Kehui Wang; Jigang Guo; Yujing Zhang; Jiangning Chen; Xing Guo; Qibin Li; Xiaoying Li; Wenjing Wang; Yan Zhang; Jin Wang; Xueyuan Jiang; Yang Xiang; Chen Xu; Pingping Zheng; Juanbin Zhang; Ruiqiang Li; Hongjie Zhang; Xiaobin Shang; Ting Gong; Guang Ning; Jun Wang; Ke Zen; Junfeng Zhang; Chen-Yu Zhang
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

7.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

8.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

Review 9.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

Review 10.  Regulation of ROCK activity in cancer.

Authors:  Marie Morgan-Fisher; Ulla M Wewer; Atsuko Yoneda
Journal:  J Histochem Cytochem       Date:  2012-11-29       Impact factor: 2.479

View more
  22 in total

1.  MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein.

Authors:  Zhe Yang; Jiong Li; Guoxing Feng; Shan Gao; Yuan Wang; Shuqin Zhang; Yunxia Liu; Lihong Ye; Yueguo Li; Xiaodong Zhang
Journal:  J Biol Chem       Date:  2017-01-19       Impact factor: 5.157

2.  Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.

Authors:  Haruhiro Yamashita; Sailesh Surapureddi; Ramesh C Kovi; Sachin Bhusari; Thai Vu Ton; Jian-Liang Li; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Cynthia V Rider; Mark J Hoenerhoff; Robert C Sills; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2020-04-18       Impact factor: 5.153

3.  Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.

Authors:  Ramzi M Mohammad; Yiwei Li; Irfana Muqbil; Amro Aboukameel; William Senapedis; Erkan Baloglu; Yosef Landesman; Philip A Philip; Asfar S Azmi
Journal:  Small GTPases       Date:  2017-06-23

4.  miR-145-5p inhibits epithelial-mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non-small cell lung cancer cells.

Authors:  Yongmei Chang; Wensen Yan; Cong Sun; Qingfeng Liu; Jun Wang; Mingzhi Wang
Journal:  Oncol Lett       Date:  2017-09-28       Impact factor: 2.967

Review 5.  Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.

Authors:  Saranya Chidambaranathan-Reghupaty; Paul B Fisher; Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2020-11-28       Impact factor: 6.242

6.  miR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40.

Authors:  Xin Guo; Lijin Yu; Min Chen; Tian Wu; Xiangdong Peng; Ren Guo; Bikui Zhang
Journal:  J Transl Med       Date:  2016-07-13       Impact factor: 5.531

7.  Role of microRNAs in inflammation-associated liver cancer.

Authors:  Lin Huan; Lin-Hui Liang; Xiang-Huo He
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

Review 8.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

9.  MicroRNA-216b reduces growth, migration and invasion of pancreatic ductal adenocarcinoma cells by directly targeting ρ-associated coiled-coil containing protein kinase 1.

Authors:  Yang-An Liu; Yue Zhang; Zhi Zheng; Kai Li; Xin-Hua Wu; Qiu-Guo Du; Xiao Ye; Lili Wang; Ling Zhu
Journal:  Oncol Lett       Date:  2018-02-23       Impact factor: 2.967

10.  Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma.

Authors:  Selena Y Lin; Adam Zhang; Jessica Lian; Jeremy Wang; Ting-Tsung Chang; Yih-Jyh Lin; Wei Song; Ying-Hsiu Su
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.